Form 4: Clorox Director Russell J. Weiner Reports Acquisition of Deferred Stock Units
SEC Form 4 Filing
Director Russell J. Weiner reports acquiring additional deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.
Summary
- Russell J. Weiner, a director of The Clorox Company, filed a Form 4 on July 2, 2024, reporting changes in beneficial ownership.
- On May 10, 2024, Weiner acquired 104.3259 deferred stock units through dividend reinvestment.
- On June 28, 2024, Weiner acquired 192.35 deferred stock units in lieu of quarterly director's fees.
- Following these transactions, Weiner beneficially owns 12,759.2726 deferred stock units.
- These deferred stock units will be settled 100% in Clorox stock upon Weiner's retirement or termination of service as a director.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard director compensation and investment, indicating confidence in the company's performance.
Positives
- The acquisition of deferred stock units demonstrates the director's continued investment in the company.
- Dividend reinvestment indicates confidence in the company's future performance.
- Receiving stock units in lieu of fees aligns the director's interests with those of the shareholders.
Future Outlook
The deferred stock units will be settled 100% in Clorox stock upon the director's retirement or termination of service.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's ongoing investment in the company.
Stakeholder Impact
- The acquisition of deferred stock units by a director can positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/10/2024 | Acquisition of 104.3259 deferred stock units through dividend reinvestment. |
| 06/28/2024 | Acquisition of 192.35 deferred stock units in lieu of quarterly director's fees. |
| 07/02/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.